• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康中国老年人无认知障碍者血浆淀粉样蛋白-β、总 tau 和磷酸化 tau181 的参考区间。

Reference intervals for plasma amyloid-β, total tau, and phosphorylated tau181 in healthy elderly Chinese individuals without cognitive impairment.

机构信息

Department of Neurology, Institute of Neuroimmunology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, 300052, China.

Division of Neuroimmunology, China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Beijing, 100070, China.

出版信息

Alzheimers Res Ther. 2023 May 26;15(1):100. doi: 10.1186/s13195-023-01246-1.

DOI:10.1186/s13195-023-01246-1
PMID:37237388
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10214719/
Abstract

BACKGROUND

Plasma amyloid-β (Aβ) peptides and tau proteins are promising biomarkers of Alzheimer's disease (AD), not only for predicting Aβ and tau pathology but also for differentiating AD from other neurodegenerative diseases. However, reference intervals for plasma biomarkers of AD in healthy elderly Chinese individuals have not yet been established.

METHODS

Biomarkers of AD were measured using single-molecule array (Simoa) assays in plasma samples from 193 healthy, cognitively unimpaired Chinese individuals aged 50-89 years. The 95% reference intervals for plasma Aβ42, Aβ40, t-tau, p-tau181, and derived ratios were calculated by using log-transformed parametric methods.

RESULTS

Plasma Aβ42, Aβ40, and p-tau181 levels were positively correlated with age, while the Aβ42/Aβ40 ratio was negatively correlated with age. The 95% reference intervals for plasma Aβ42 and Aβ40 were 2.72-11.09 pg/mL and 61.4-303.9 pg/mL, respectively, and the 95% reference intervals for plasma t-tau and p-tau181 were 0.20-3.12 pg/mL and 0.49-3.29 pg/mL, respectively. The 95% reference intervals for the Aβ42/Aβ40 ratio, p-tau181/t-tau ratio, and p-tau181/Aβ42 ratio were 0.022-0.064, 0.38-6.34, and 0.05-0.55, respectively.

CONCLUSION

Reference intervals for plasma biomarkers of AD may assist clinicians in making accurate clinical decisions.

摘要

背景

血浆淀粉样蛋白-β(Aβ)肽和 tau 蛋白是阿尔茨海默病(AD)有前途的生物标志物,不仅可用于预测 Aβ 和 tau 病理学,还可用于区分 AD 与其他神经退行性疾病。然而,尚未建立健康中国老年人血浆 AD 生物标志物的参考区间。

方法

使用单分子阵列(Simoa)测定 193 名 50-89 岁认知正常的中国健康个体的血浆样本中的 AD 生物标志物。通过对数转换参数方法计算血浆 Aβ42、Aβ40、t-tau、p-tau181 和衍生比值的 95%参考区间。

结果

血浆 Aβ42、Aβ40 和 p-tau181 水平与年龄呈正相关,而 Aβ42/Aβ40 比值与年龄呈负相关。血浆 Aβ42 和 Aβ40 的 95%参考区间分别为 2.72-11.09 pg/mL 和 61.4-303.9 pg/mL,血浆 t-tau 和 p-tau181 的 95%参考区间分别为 0.20-3.12 pg/mL 和 0.49-3.29 pg/mL。Aβ42/Aβ40 比值、p-tau181/t-tau 比值和 p-tau181/Aβ42 比值的 95%参考区间分别为 0.022-0.064、0.38-6.34 和 0.05-0.55。

结论

AD 血浆生物标志物的参考区间可能有助于临床医生做出准确的临床决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d9/10214719/254cd618dd04/13195_2023_1246_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d9/10214719/254cd618dd04/13195_2023_1246_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d9/10214719/254cd618dd04/13195_2023_1246_Fig1_HTML.jpg

相似文献

1
Reference intervals for plasma amyloid-β, total tau, and phosphorylated tau181 in healthy elderly Chinese individuals without cognitive impairment.健康中国老年人无认知障碍者血浆淀粉样蛋白-β、总 tau 和磷酸化 tau181 的参考区间。
Alzheimers Res Ther. 2023 May 26;15(1):100. doi: 10.1186/s13195-023-01246-1.
2
Plasma Core Alzheimer's Disease Biomarkers Predict Amyloid Deposition Burden by Positron Emission Tomography in Chinese Individuals with Cognitive Decline.血浆核心阿尔茨海默病生物标志物可通过正电子发射断层扫描预测认知功能减退中国个体的淀粉样蛋白沉积负担。
ACS Chem Neurosci. 2023 Jan 4;14(1):170-179. doi: 10.1021/acschemneuro.2c00636. Epub 2022 Dec 22.
3
Astrocyte reactivity is associated with tau tangle load and cortical thinning in Alzheimer's disease.星形胶质细胞反应性与阿尔茨海默病中的 tau 缠结负荷和皮质变薄有关。
Mol Neurodegener. 2024 Jul 30;19(1):58. doi: 10.1186/s13024-024-00750-8.
4
Correlation between Cerebrospinal Fluid Core Alzheimer's Disease Biomarkers and β-Amyloid PET in Chinese Dementia Population.中国痴呆人群中脑脊液核心阿尔茨海默病生物标志物与β-淀粉样蛋白 PET 的相关性。
ACS Chem Neurosci. 2022 May 18;13(10):1558-1565. doi: 10.1021/acschemneuro.2c00120. Epub 2022 Apr 27.
5
Plasma p-tau231, p-tau181, PET Biomarkers, and Cognitive Change in Older Adults.老年人血浆 p-tau231、p-tau181、PET 生物标志物与认知变化。
Ann Neurol. 2022 Apr;91(4):548-560. doi: 10.1002/ana.26308. Epub 2022 Feb 18.
6
Exploring the potential of fully automated LUMIPULSE G plasma assays for detecting Alzheimer's disease pathology.探索全自动 LUMIPULSE G 血浆检测在检测阿尔茨海默病病理方面的潜力。
Alzheimers Res Ther. 2024 Mar 7;16(1):51. doi: 10.1186/s13195-024-01397-9.
7
The dynamics of plasma biomarkers across the Alzheimer's continuum.阿尔茨海默病连续体中血浆生物标志物的动态变化。
Alzheimers Res Ther. 2023 Feb 8;15(1):31. doi: 10.1186/s13195-023-01174-0.
8
Plasma P-tau181 to Aβ42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant cerebrovascular disease.血浆 P-tau181 与 Aβ42 比值与伴有脑血管病的亚洲阿尔茨海默病患者的脑淀粉样蛋白负荷和海马萎缩相关。
Alzheimers Dement. 2021 Oct;17(10):1649-1662. doi: 10.1002/alz.12332. Epub 2021 Mar 31.
9
Predictive Accuracy of Blood-Derived Biomarkers for Amyloid-β Brain Deposition Along with the Alzheimer's Disease Continuum: A Systematic Review.血源性生物标志物预测淀粉样β脑沉积与阿尔茨海默病连续体的准确性:系统评价。
J Alzheimers Dis. 2021;84(1):393-407. doi: 10.3233/JAD-210496.
10
Associations of plasma phosphorylated tau181 and neurofilament light chain with brain amyloid burden and cognition in objectively defined subtle cognitive decline patients.在客观定义的轻度认知障碍患者中,血浆磷酸化 tau181 和神经丝轻链与脑淀粉样蛋白负担和认知的相关性。
CNS Neurosci Ther. 2022 Dec;28(12):2195-2205. doi: 10.1111/cns.13962. Epub 2022 Sep 8.

引用本文的文献

1
Associations of Plasma p-tau181 With Age, Adjusted for Kidney Function and Sociodemographic Factors.血浆p-tau181与年龄的关联,经肾功能和社会人口学因素校正。
Int J Geriatr Psychiatry. 2025 Aug;40(8):e70138. doi: 10.1002/gps.70138.
2
Alterations in CNS-derived blood biomarkers during 30 days simulated microgravity.30天模拟微重力期间中枢神经系统衍生血液生物标志物的变化。
Front Physiol. 2025 Jun 24;16:1600708. doi: 10.3389/fphys.2025.1600708. eCollection 2025.
3
Plasma and MRI biomarkers capture neuronal damage in former professional boxers.

本文引用的文献

1
Performance of plasma phosphorylated tau 181 and 217 in the community.社区人群中血浆磷酸化 tau181 和 tau217 的检测性能。
Nat Med. 2022 Jul;28(7):1398-1405. doi: 10.1038/s41591-022-01822-2. Epub 2022 May 26.
2
Medical comorbidities and ethnicity impact plasma Alzheimer's disease biomarkers: Important considerations for clinical trials and practice.医学合并症和种族影响血浆阿尔茨海默病生物标志物:临床试验和实践中的重要考量因素。
Alzheimers Dement. 2023 Jan;19(1):36-43. doi: 10.1002/alz.12647. Epub 2022 Mar 2.
3
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation.
血浆和核磁共振成像生物标志物可捕捉前职业拳击手的神经元损伤情况。
Sci Rep. 2025 Jun 6;15(1):20005. doi: 10.1038/s41598-025-93066-6.
4
Plasma biomarkers for diagnosis and differentiation and their cognitive correlations in patients with Alzheimer's disease.阿尔茨海默病患者诊断与鉴别诊断的血浆生物标志物及其认知相关性
Brain Commun. 2025 Feb 25;7(2):fcaf094. doi: 10.1093/braincomms/fcaf094. eCollection 2025.
5
Diagnostic and discriminative accuracy of plasma phosphorylated tau 217 for symptomatic Alzheimer's disease in a Chinese cohort.血浆磷酸化tau 217对中国队列中有症状阿尔茨海默病的诊断及鉴别准确性
J Prev Alzheimers Dis. 2025 May;12(5):100092. doi: 10.1016/j.tjpad.2025.100092. Epub 2025 Feb 12.
6
Biofluid biomarkers for Alzheimer's disease: past, present, and future.用于阿尔茨海默病的生物流体生物标志物:过去、现在和未来。
Med Rev (2021). 2024 Oct 17;4(6):467-491. doi: 10.1515/mr-2023-0071. eCollection 2024 Dec.
7
Preliminary reference values for Alzheimer's disease plasma biomarkers in Congolese individuals with and without dementia.刚果有或无痴呆症个体中阿尔茨海默病血浆生物标志物的初步参考值。
Front Aging Neurosci. 2024 Nov 21;16:1477047. doi: 10.3389/fnagi.2024.1477047. eCollection 2024.
8
Heritability of Alzheimer's disease plasma biomarkers: A nuclear twin family design.阿尔茨海默病血浆生物标志物的遗传度:一项核孪生家族研究设计。
Alzheimers Dement. 2025 Jan;21(1):e14269. doi: 10.1002/alz.14269. Epub 2024 Nov 26.
9
CSF and Plasma Biomarkers in Patients With Iatrogenic Cerebral Amyloid Angiopathy.医源性脑淀粉样血管病患者的脑脊液和血浆生物标志物
Neurology. 2024 Oct 22;103(8):e209828. doi: 10.1212/WNL.0000000000209828. Epub 2024 Sep 16.
10
Clinical utility of plasma Aβ42/40 ratio by LC-MS/MS in Alzheimer's disease assessment.液相色谱-串联质谱法检测血浆Aβ42/40比值在阿尔茨海默病评估中的临床应用
Front Neurol. 2024 Mar 25;15:1364658. doi: 10.3389/fneur.2024.1364658. eCollection 2024.
用于阿尔茨海默病的血液生物标志物:迈向临床应用
Lancet Neurol. 2022 Jan;21(1):66-77. doi: 10.1016/S1474-4422(21)00361-6. Epub 2021 Nov 24.
4
Structural differences in amyloid-β fibrils from brains of nondemented elderly individuals and Alzheimer's disease patients.淀粉样β纤维在无痴呆的老年个体和阿尔茨海默病患者大脑中的结构差异。
Proc Natl Acad Sci U S A. 2021 Nov 9;118(45). doi: 10.1073/pnas.2111863118.
5
Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities.淀粉样蛋白和神经退行性变血浆生物标志物与共病的关联。
Alzheimers Dement. 2022 Jun;18(6):1128-1140. doi: 10.1002/alz.12466. Epub 2021 Sep 27.
6
Cellular and pathological heterogeneity of primary tauopathies.原发性 tau 病的细胞和病理学异质性。
Mol Neurodegener. 2021 Aug 23;16(1):57. doi: 10.1186/s13024-021-00476-x.
7
Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group.阿尔茨海默病的临床诊断:国际工作组的建议。
Lancet Neurol. 2021 Jun;20(6):484-496. doi: 10.1016/S1474-4422(21)00066-1. Epub 2021 Apr 29.
8
Plasma P-tau181 to Aβ42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant cerebrovascular disease.血浆 P-tau181 与 Aβ42 比值与伴有脑血管病的亚洲阿尔茨海默病患者的脑淀粉样蛋白负荷和海马萎缩相关。
Alzheimers Dement. 2021 Oct;17(10):1649-1662. doi: 10.1002/alz.12332. Epub 2021 Mar 31.
9
The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease.血浆生物标志物在阿尔茨海默病中的诊断和预后能力。
Alzheimers Dement. 2021 Jul;17(7):1145-1156. doi: 10.1002/alz.12283. Epub 2021 Jan 25.
10
Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.阿尔茨海默病谱中血液磷酸化 tau181 的时间进程。
Brain. 2021 Feb 12;144(1):325-339. doi: 10.1093/brain/awaa399.